Skip Navigation

European Journal of Heart Failure 2002 4(1):23-31; doi:10.1016/S1388-9842(01)00226-4
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Haase, D.
Right arrow Articles by Figulla, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haase, D.
Right arrow Articles by Figulla, H. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 European Society of Cardiology

Identification and validation of selective upregulation of ventricular myosin light chain type 2 mRNA in idiopathic dilated cardiomyopathy

Daniela Haasea, Michael H. Lehmanna, Michael M. Körnerb, Reiner Körferb, Holger H. Siguscha,* and Hans R. Figullaa

a Department of Internal Medicine, Division of Cardiology, University of Jena 07740 Jena, Germany
b Department of Cardiac Surgery, Heart Center NRW, Ruhr-University of Bochum Bad Oeynhausen, Germany

* Corresponding author. Tel.: +49-3641-939-360; fax: +49-3641-939-290. E-mail address: holger.sigusch{at}uni-jena.de


  Abstract

Background and aims: the etiology of idiopathic dilated cardiomyopathy (IDCM) is unknown, methods such as suppression subtractive hybridization (SSH) and DNA microarray technology can help to identify genes which might be involved in the pathogenesis of this disease.

Methods and results: we used SSH which compared mRNA populations extracted from the left ventricular tissue of IDCM hearts and from the control tissue to identify sequences which correspond to genes up-regulated in IDCM. We identified ventricular myosin light chain type 2 (MLC2V), skeletal {alpha}-actin, long-chain-acyl-CoA-synthetase and mRNA for the protein KIAA0465 as differentially up-regulated genes. Expression of MLC2V mRNA was determined by RT-PCR in patients with end-stage heart failure caused by IDCM (n=11) or coronary artery disease (CAD, n=9) who underwent heart transplantation as well as the controls (n=6). MLC2V/GAPDH ratios were 2.95±0.32, 0.69±0.03 and 0.28±0.08 (arbitrary unit) for the IDCM group, the CAD group and controls, respectively (P<0.05). DNA microarray analysis confirmed the finding of MLC2V upregulation in IDCM (3.7- and 1.8-fold increase in MLC2V mRNA).

Conclusions: we have demonstrated that SSH is a useful method to identify differential myocardial upregulation of genes. Upregulation of MLC2V can be judged as a specific IDCM related feature, which might be clinically helpful.

Key Words: Cardiomyopathy • Candidate genes • Subtractive hybridization • DNA microarray • Myosin light chain

Received March 22, 2001; Revised June 25, 2001; Accepted September 7, 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.